<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>贝壳社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-09T20:21:54+08:00</updated>
  <subtitle>贝壳社是国内领先的医疗健康创新创业服务平台，集聚政府、上市公司、投资机构和三甲医院等产业高端资源，提供一站式的全球生命健康人才项目引进、转化孵化和产业化等全产业链协同创新和赋能服务。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>心脏支架从1.3万降至700！新冠试剂120降至8.88！IVD大降价口从哪儿开？</title>
    <updated>2020-11-09T17:23:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/R5f9-tgLNcmwAJTUewqb1A</id>
    <link href="https://mp.weixin.qq.com/s/R5f9-tgLNcmwAJTUewqb1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创响生物完成2100万美元B轮融资</title>
    <updated>2020-11-09T17:23:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/4lvpEefRdJqSxwbool4tjQ</id>
    <link href="https://mp.weixin.qq.com/s/4lvpEefRdJqSxwbool4tjQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞JAK 抑制剂达到3期临床终点，有望斩获第5个适应症；国家医保局发文，药企机会来了 | 贝壳日报</title>
    <updated>2020-11-09T17:23:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/XRL7GBpODbmhDbFZyrahfw</id>
    <link href="https://mp.weixin.qq.com/s/XRL7GBpODbmhDbFZyrahfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今年市场热点——新一代肿瘤免疫靶点</title>
    <updated>2020-11-06T17:34:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/PzZ4ueYCvcEEgoP8KR4WRw</id>
    <link href="https://mp.weixin.qq.com/s/PzZ4ueYCvcEEgoP8KR4WRw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅 | 贝壳大学校董余国良博士又下一城，冠科美博完成1.24亿美元C轮融资</title>
    <updated>2020-11-06T11:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/PyGB3KCZWlPvDgDM0l3mMg</id>
    <link href="https://mp.weixin.qq.com/s/PyGB3KCZWlPvDgDM0l3mMg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>检验阿尔茨海默病“微生物感染”假说，2/3期临床试验完成患者注册 ；公卫、家签补助标准明确 | 贝壳日报</title>
    <updated>2020-11-06T11:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/RhixLvhPJCCio4yeeGufsg</id>
    <link href="https://mp.weixin.qq.com/s/RhixLvhPJCCio4yeeGufsg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>助力创新 赋能新活力——默克初创企业关怀计划上线</title>
    <updated>2020-11-05T16:14:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/QnNKVgq7bx8gqZOZBxxIyg</id>
    <link href="https://mp.weixin.qq.com/s/QnNKVgq7bx8gqZOZBxxIyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>集采风暴又来了！冠脉支架拟中选结果公布，最高降幅96%！</title>
    <updated>2020-11-05T16:14:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/6RaUmi8RgX5lrXzPA4R-jg</id>
    <link href="https://mp.weixin.qq.com/s/6RaUmi8RgX5lrXzPA4R-jg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CRISPR基因编辑疗法公布最新临床结果 ；欧盟EMA接受JAK1抑制剂新适应症申请，治疗溃疡性结肠炎 | 贝壳日报</title>
    <updated>2020-11-05T16:14:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/mSUOvgyGNA8wAk0YIrPrZQ</id>
    <link href="https://mp.weixin.qq.com/s/mSUOvgyGNA8wAk0YIrPrZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“研发英雄” 群雄逐鹿，2020勃林格殷格翰创新大赛中国创新冠军诞生</title>
    <updated>2020-11-04T09:52:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/8HrsrUVGKGnV8hE3quW9eg</id>
    <link href="https://mp.weixin.qq.com/s/8HrsrUVGKGnV8hE3quW9eg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>TYK2抑制剂首个关键性3期临床结果积极，显著改善银屑病患者症状 ； FDA有望批准首款软骨发育不全疗法 | 贝壳日报</title>
    <updated>2020-11-04T09:52:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/KQqKu5LLg4oTRVRUsC4j9Q</id>
    <link href="https://mp.weixin.qq.com/s/KQqKu5LLg4oTRVRUsC4j9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1将成新药投资滑铁卢！还有靶点正重蹈PD-1覆辙，涉15家企业</title>
    <updated>2020-11-03T17:29:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/mbML-LnjgEpw5um04ZDhaQ</id>
    <link href="https://mp.weixin.qq.com/s/mbML-LnjgEpw5um04ZDhaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚，国家医保局发文，明确互联网医疗报销方案 ；囊获自然杀伤细胞管线，赛诺菲拟斥资3.08亿欧元收购Kiadis | 贝壳日报</title>
    <updated>2020-11-03T17:29:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/tlWmqcpuNAZd_4tLRAyN2A</id>
    <link href="https://mp.weixin.qq.com/s/tlWmqcpuNAZd_4tLRAyN2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ADC药物：过去的十年</title>
    <updated>2020-11-02T17:30:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/hZDqSTdiyVwQbTGfYKkDUg</id>
    <link href="https://mp.weixin.qq.com/s/hZDqSTdiyVwQbTGfYKkDUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Sana公司“招兵买马”，为治疗CNS疾病添加新工具；第三批国采进入执行期，186个药遭踢 | 贝壳日报</title>
    <updated>2020-11-02T17:30:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/isW4Q70ro4OgYPJ8u2tzNQ</id>
    <link href="https://mp.weixin.qq.com/s/isW4Q70ro4OgYPJ8u2tzNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature 综述 | 基因治疗全解析</title>
    <updated>2020-10-31T17:30:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/Z32IgMgVX942P3VKBoojjw</id>
    <link href="https://mp.weixin.qq.com/s/Z32IgMgVX942P3VKBoojjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百年沉浮！肿瘤免疫治疗简史</title>
    <updated>2020-10-30T17:45:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/Qj5U_CZBwLe1emCpdQrA-A</id>
    <link href="https://mp.weixin.qq.com/s/Qj5U_CZBwLe1emCpdQrA-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维立志博完成近2亿新一轮融资，加速推进抗肿瘤新药研发</title>
    <updated>2020-10-30T17:45:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/5rdF7D0hbzj7_aEPwBomgw</id>
    <link href="https://mp.weixin.qq.com/s/5rdF7D0hbzj7_aEPwBomgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>结合机器学习与干细胞技术，百时美施贵宝合作开发神经退行性疾病疗法；开发多特异性新冠病毒中和疗法，诺华达成研发合作 | 贝壳日报</title>
    <updated>2020-10-30T17:45:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/W0NgeFSFBssgzofryOSC4w</id>
    <link href="https://mp.weixin.qq.com/s/W0NgeFSFBssgzofryOSC4w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝壳社、青蓝港湾受邀出席2020“善洽会”，共绘长三角生命健康产业发展蓝图</title>
    <updated>2020-10-29T17:19:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/kghMsEf83dGPgdh1yZx1fQ</id>
    <link href="https://mp.weixin.qq.com/s/kghMsEf83dGPgdh1yZx1fQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>